Suppr
超能文献

Metabolic modulation by CDK4/6 inhibitor promotes chemokine-mediated recruitment of T cells into mammary tumors.

作者信息

Uzhachenko Roman V, Bharti Vijaya, Ouyang Zhufeng, Blevins Ashlyn, Mont Stacey, Saleh Nabil, Lawrence Hunter A, Shen Chengli, Chen Sheau-Chiann, Ayers Gregory D, DeNardo David G, Arteaga Carlos, Richmond Ann, Vilgelm Anna E

出版信息

Cell Rep. 2021 Jun 22;35(12):109271. doi: 10.1016/j.celrep.2021.109271.

DOI:10.1016/j.celrep.2021.109271

PMID:34161761

Abstract

摘要

相似文献

Metabolic modulation by CDK4/6 inhibitor promotes chemokine-mediated recruitment of T cells into mammary tumors.

Cell Rep. 2021 Jun 22;35(12):109271. doi: 10.1016/j.celrep.2021.109271.

Mouse mammary hyperplasias and neoplasias exhibit different patterns of cyclins D1 and D2 binding to cdk4.

Carcinogenesis. 1995 Oct;16(10):2507-13. doi: 10.1093/carcin/16.10.2507.

CDK4/6 inhibition promotes immune infiltration in ovarian cancer and synergizes with PD-1 blockade in a B cell-dependent manner.

Theranostics. 2020 Aug 25;10(23):10619-10633. doi: 10.7150/thno.44871. eCollection 2020.

IFNγ-induced Chemokines Are Required for CXCR3-mediated T-Cell Recruitment and Antitumor Efficacy of Anti-HER2/CD3 Bispecific Antibody.

Clin Cancer Res. 2018 Dec 15;24(24):6447-6458. doi: 10.1158/1078-0432.CCR-18-1139. Epub 2018 Jun 27.

Activation of CD8 T Cells Contributes to Antitumor Effects of CDK4/6 Inhibitors plus MEK Inhibitors.

Cancer Immunol Res. 2020 Sep;8(9):1114-1121. doi: 10.1158/2326-6066.CIR-19-0743. Epub 2020 Jul 13.

Efficacy of a combination therapy targeting CDK4/6 and autophagy in a mouse xenograft model of t(8;21) acute myeloid leukemia.

Biochem Biophys Rep. 2021 Aug 13;27:101099. doi: 10.1016/j.bbrep.2021.101099. eCollection 2021 Sep.

Acquired CDK6 amplification promotes breast cancer resistance to CDK4/6 inhibitors and loss of ER signaling and dependence.

Oncogene. 2017 Apr 20;36(16):2255-2264. doi: 10.1038/onc.2016.379. Epub 2016 Oct 17.

In vitro study to assess the efficacy of CDK4/6 inhibitor Palbociclib (PD-0332991) for treating canine mammary tumours.

Vet Comp Oncol. 2019 Dec;17(4):507-521. doi: 10.1111/vco.12514. Epub 2019 Jul 12.

Connecting the Dots: Therapy-Induced Senescence and a Tumor-Suppressive Immune Microenvironment.

J Natl Cancer Inst. 2015 Dec 30;108(6):djv406. doi: 10.1093/jnci/djv406. Print 2016 Jun.

Immune-mediated modulation of breast cancer growth and metastasis by the chemokine Mig (CXCL9) in a murine model.

J Immunother. 2007 Jul-Aug;30(5):490-8. doi: 10.1097/CJI.0b013e318031b551.

引用本文的文献

TTK inhibitor OSU13 promotes immunotherapy responses by activating tumor STING.

JCI Insight. 2024 Jun 20;9(15):e177523. doi: 10.1172/jci.insight.177523.

The Evolving Pathways of the Efficacy of and Resistance to CDK4/6 Inhibitors in Breast Cancer.

Cancers (Basel). 2023 Oct 2;15(19):4835. doi: 10.3390/cancers15194835.

SPAG5 Expression Predicts Poor Prognosis and is Associated With Adverse Immune Infiltration in Lung Adenocarcinomas.

Clin Med Insights Oncol. 2023 Sep 22;17:11795549231199915. doi: 10.1177/11795549231199915. eCollection 2023.

Durable responses to alectinib in murine models of EML4-ALK lung cancer requires adaptive immunity.

NPJ Precis Oncol. 2023 Feb 4;7(1):15. doi: 10.1038/s41698-023-00355-2.

Novel EGFR-mutant mouse models of lung adenocarcinoma reveal adaptive immunity requirement for durable osimertinib response.

Cancer Lett. 2023 Mar 1;556:216062. doi: 10.1016/j.canlet.2023.216062. Epub 2023 Jan 16.

Preclinical evaluation of CDK4 phosphorylation predicts high sensitivity of pleural mesotheliomas to CDK4/6 inhibition.

Mol Oncol. 2024 Apr;18(4):866-894. doi: 10.1002/1878-0261.13351. Epub 2022 Dec 19.

Harnessing the immunotherapeutic potential of CDK4/6 inhibitors in melanoma: is timing everything?

NPJ Precis Oncol. 2022 Apr 20;6(1):26. doi: 10.1038/s41698-022-00273-9.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Suppr超能文献

Metabolic modulation by CDK4/6 inhibitor promotes chemokine-mediated recruitment of T cells into mammary tumors.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译